Hyperhomocysteinemia in patients with riboflavin‐responsive multiple acyl‐CoA dehydrogenase deficiency
Muscle & Nerve · 2023
DOI: 10.1002/mus.27960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Huiqiu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Hospital, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Multiple Acyl Coenzyme A Dehydrogenase Deficiency, Hyperhomocysteinemia, Riboflavin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Shanxi Science and Technology Department, Shanxi Provincial Science and Technology Department.
Abstract (Originalsprache)
Introduction/Aims Riboflavin‐responsive multiple acyl‐CoA dehydrogenase deficiency (RR‐MADD) is an autosomal recessive disease chiefly caused by variants of ETFDH affecting fatty acid metabolism. In our cohort, hyperhomocysteinemia (HHcy) was common. In this study we aimed to identify the association between RR‐MADD and HHcy.
Methods
We performed a retrospective review of 13 patients with RR‐MADD. Thirty‐three healthy controls were recruited, and logistic regression was used to investigate the association between RR‐MADD and HHcy. Muscle tissues from six patients and six controls without myopathies were collected to measure the levels of flavin adenine dinucleotide (FAD), an active form of riboflavin. Whole‐exome sequencing was performed to identify the disease‐associated variants.
Results
The RR‐MADD patients had a higher prevalence of HHcy (9 of 12) than controls (6 of 33, P < .001). In the multivariate analysis, RR‐MADD was positively related to HHcy ( P = .014). Muscular FAD levels were decreased in RR‐MADD patients ( P = .006). Thirteen variants (8 reported and 5 novel) were identified in ETFDH. Of these, c.250G > A was the most common pathogenic variant with an allelic frequency of 4 of 20.
Discussion
HHcy was associated with RR‐MADD and may aid in the diagnosis of the disease. Our findings expand the mutational spectrum of RR‐MADD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, First Hospital, Shanxi Medical University, Taiyuan, China.
- First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Wei Zhang
Förderung
- Shanxi Science and Technology Department
- Shanxi Provincial Science and Technology Department
Zitieren
APA
Zhang, H., Zhao, R., Ma, J., Zhang, J., Wang, J., Chang, X., Guo, J., & Zhang, W. (2023). Hyperhomocysteinemia in patients with riboflavin‐responsive multiple acyl‐CoA dehydrogenase deficiency. Muscle & Nerve. https://doi.org/10.1002/mus.27960
Vancouver
Zhang H, Zhao R, Ma J, Zhang J, Wang J, Chang X, et al. Hyperhomocysteinemia in patients with riboflavin‐responsive multiple acyl‐CoA dehydrogenase deficiency. Muscle & Nerve. 2023. doi:10.1002/mus.27960
BibTeX
@article{Zhang2023,
author = {Zhang, Huiqiu and Zhao, Rongjuan and Ma, Jing and Zhang, Jingfei and Wang, Juan and Chang, Xueli and Guo, Junhong and Zhang, Wei},
title = {Hyperhomocysteinemia in patients with riboflavin‐responsive multiple acyl‐CoA dehydrogenase deficiency},
journal = {Muscle & Nerve},
year = {2023},
doi = {10.1002/mus.27960}
}
EUVIMED